Вклад участника
- 21:38, 18 апреля 2024 (разн. | история) . . (+3484) . . Н Costeffectiveness-examination-regarding-very-first-along-with-secondgeneration-EGFR-tyrosine-kinase-inhibitors-while-very-first-type-of-answer-to-individuals-together-with-NSCLC-holding-EGFR-strains-k (Costeffectiveness-examination-regarding-very-first-along-with-secondgeneration-EGFR-tyrosine-kinase-inhibitors-while-very-first-type-of-answer-to-individuals-together-with-NSCLC-holding-EGFR-strains-k) (текущая)